Literature DB >> 31433971

The Immune Landscape of Cancer.

Vésteinn Thorsson1, David L Gibbs2, Scott D Brown3, Denise Wolf4, Dante S Bortone5, Tai-Hsien Ou Yang6, Eduard Porta-Pardo7, Galen F Gao8, Christopher L Plaisier9, James A Eddy10, Elad Ziv11, Aedin C Culhane12, Evan O Paull13, I K Ashok Sivakumar14, Andrew J Gentles15, Raunaq Malhotra16, Farshad Farshidfar17, Antonio Colaprico18, Joel S Parker5, Lisle E Mose5, Nam Sy Vo19, Jianfang Liu20, Yuexin Liu19, Janet Rader21, Varsha Dhankani2, Sheila M Reynolds2, Reanne Bowlby3, Andrea Califano13, Andrew D Cherniack8, Dimitris Anastassiou6, Davide Bedognetti22, Younes Mokrab22, Aaron M Newman23, Arvind Rao19, Ken Chen19, Alexander Krasnitz24, Hai Hu20, Tathiane M Malta25, Houtan Noushmehr25, Chandra Sekhar Pedamallu26, Susan Bullman26, Akinyemi I Ojesina27, Andrew Lamb10, Wanding Zhou28, Hui Shen28, Toni K Choueiri26, John N Weinstein19, Justin Guinney10, Joel Saltz29, Robert A Holt3, Charles S Rabkin30, Alexander J Lazar31, Jonathan S Serody32, Elizabeth G Demicco33, Mary L Disis34, Benjamin G Vincent35, Ilya Shmulevich36.   

Abstract

Entities:  

Year:  2019        PMID: 31433971     DOI: 10.1016/j.immuni.2019.08.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


× No keyword cloud information.
  122 in total

1.  Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.

Authors:  Masanori Oshi; Shipra Gandhi; Li Yan; Yoshihisa Tokumaru; Rongrong Wu; Akimitsu Yamada; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-05-31       Impact factor: 4.872

2.  Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.

Authors:  Zhujiang Dai; Xiang Peng; Yuegui Guo; Xia Shen; Wenjun Ding; Jihong Fu; Zhonglin Liang; Jinglue Song
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-22       Impact factor: 4.553

3.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.

Authors:  Karsten Krug; Eric J Jaehnig; Shankha Satpathy; Lili Blumenberg; Alla Karpova; Meenakshi Anurag; George Miles; Philipp Mertins; Yifat Geffen; Lauren C Tang; David I Heiman; Song Cao; Yosef E Maruvka; Jonathan T Lei; Chen Huang; Ramani B Kothadia; Antonio Colaprico; Chet Birger; Jarey Wang; Yongchao Dou; Bo Wen; Zhiao Shi; Yuxing Liao; Maciej Wiznerowicz; Matthew A Wyczalkowski; Xi Steven Chen; Jacob J Kennedy; Amanda G Paulovich; Mathangi Thiagarajan; Christopher R Kinsinger; Tara Hiltke; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Thomas F Westbrook; Li Ding; Gad Getz; Karl R Clauser; David Fenyö; Kelly V Ruggles; Bing Zhang; D R Mani; Steven A Carr; Matthew J Ellis; Michael A Gillette
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

4.  G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.

Authors:  Masanori Oshi; Ankit Patel; Lan Le; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

5.  Large-Scale Topological Changes Restrain Malignant Progression in Colorectal Cancer.

Authors:  Sarah E Johnstone; Alejandro Reyes; Yifeng Qi; Carmen Adriaens; Esmat Hegazi; Karin Pelka; Jonathan H Chen; Luli S Zou; Yotam Drier; Vivian Hecht; Noam Shoresh; Martin K Selig; Caleb A Lareau; Sowmya Iyer; Son C Nguyen; Eric F Joyce; Nir Hacohen; Rafael A Irizarry; Bin Zhang; Martin J Aryee; Bradley E Bernstein
Journal:  Cell       Date:  2020-08-24       Impact factor: 41.582

6.  Molecular Mechanisms of Hepatoblastoma.

Authors:  Yi Zhang; Antonio Solinas; Stefano Cairo; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Semin Liver Dis       Date:  2021-01-20       Impact factor: 6.115

7.  CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.

Authors:  Sushil Kumar; Zexian Zeng; Archis Bagati; Rong En Tay; Lionel A Sanz; Stella R Hartono; Yoshinaga Ito; Fieda Abderazzaq; Elodie Hatchi; Peng Jiang; Adam N R Cartwright; Olamide Olawoyin; Nathan D Mathewson; Jason W Pyrdol; Mamie Z Li; John G Doench; Matthew A Booker; Michael Y Tolstorukov; Stephen J Elledge; Frédéric Chédin; X Shirley Liu; Kai W Wucherpfennig
Journal:  Cancer Discov       Date:  2021-03-11       Impact factor: 39.397

8.  A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Authors:  Masanori Oshi; Fernando A Angarita; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-05-16       Impact factor: 6.639

9.  Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment.

Authors:  Shipra Gandhi; Masanori Oshi; Vijayashree Murthy; Elizabeth A Repasky; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.575

Review 10.  Liver Cancer Immunity.

Authors:  Sumera Rizvi; Juan Wang; Anthony B El-Khoueiry
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.